Is Amanaya Ventures overvalued or undervalued?
As of October 8, 2025, Amanaya Ventures is considered undervalued with a PE ratio of 6.11 and strong recent performance, despite a year-to-date decline of 9.62%, indicating potential for growth compared to its peers and the broader market.
As of 8 October 2025, Amanaya Ventures has moved from a very attractive to an attractive valuation grade. The company is currently deemed undervalued, with a PE ratio of 6.11, an EV to EBIT of 5.00, and an EV to EBITDA also at 5.00. These ratios indicate that the company is trading at a significant discount compared to its peers, particularly when looking at Elitecon International, which has a PE ratio of 344.31, and MMTC with a PE of 149.82.In comparison to the broader market, Amanaya Ventures has shown a strong performance over the past week and month, with returns of 7.21% compared to the Sensex's 0.98% and 1.22%, respectively. However, the year-to-date performance shows a decline of 9.62%, contrasting with the Sensex's gain of 4.65%. Overall, the valuation metrics suggest that Amanaya Ventures is positioned favorably within its industry, indicating potential for growth and investment appeal.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
